The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities
- 15 April 2020
- journal article
- research article
- Published by Elsevier in Journal of Critical Care
- Vol. 58, 58-64
Abstract
No abstract availableKeywords
Funding Information
- Clinical Center
- National Heart, Lung, and Blood Institute
- National Institutes of Health
This publication has 40 references indexed in Scilit:
- Albumin Replacement in Patients with Severe Sepsis or Septic ShockNew England Journal of Medicine, 2014
- Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging TherapiesThe Cancer Journal, 2014
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic LeukemiaScience Translational Medicine, 2014
- Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: a systematic review and meta-analysisCritical Care, 2014
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic LeukemiaScience Translational Medicine, 2013
- Association Between a Chloride-Liberal vs Chloride-Restrictive Intravenous Fluid Administration Strategy and Kidney Injury in Critically Ill AdultsJAMA, 2012
- Noninvasive versus invasive ventilation for acute respiratory failure in patients with hematologic malignancies: A 5-year multicenter observational survey*Critical Care Medicine, 2011
- Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancyIntensive Care Medicine, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study*Critical Care Medicine, 2006